Victory Capital Management Inc 10x Genomics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 12,637 shares of TXG stock, worth $199,917. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,637

Previous 12,728 0.71%

Holding current value

$199,917

Previous $247,000 15.38%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$15.71 - $23.49 $1,429 - $2,137	-91 Reduced 0.71%	12,637 $285,000
Q2 2024 Aug 05, 2024	SELL	$19.45 - $37.37 $3,948 - $7,586	-203 Reduced 1.57%	12,728 $247,000
Q1 2024 May 03, 2024	BUY	$36.08 - $54.3 $6,963 - $10,479	193 Added 1.52%	12,931 $485,000
Q4 2023 Feb 05, 2024	BUY	$34.32 - $57.55 $86,314 - $144,738	2,515 Added 24.6%	12,738 $712,000
Q3 2023 Nov 06, 2023	SELL	$40.86 - $62.98 $664,424 - $1.02 Million	-16,261 Reduced 61.4%	10,223 $421,000
Q2 2023 Jul 27, 2023	SELL	$50.96 - $58.72 $63,241 - $72,871	-1,241 Reduced 4.48%	26,484 $1.48 Million
Q1 2023 May 02, 2023	BUY	$35.33 - $55.79 $636,540 - $1.01 Million	18,017 Added 185.59%	27,725 $1.55 Million
Q4 2022 Feb 10, 2023	BUY	$24.4 - $41.3 $2,147 - $3,634	88 Added 0.91%	9,708 $353,000
Q4 2022 Feb 09, 2023	SELL	$24.4 - $41.3 $2,269 - $3,840	-93 Reduced 0.96%	9,620 $350,000
Q3 2022 Nov 02, 2022	BUY	$28.48 - $52.59 $276,626 - $510,806	9,713 New	9,713 $277,000
Q1 2022 May 04, 2022	SELL	$55.7 - $145.79 $1.31 Million - $3.43 Million	-23,560 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$135.05 - $182.59 $2.9 Million - $3.92 Million	-21,455 Reduced 47.66%	23,560 $3.51 Million
Q3 2021 Nov 02, 2021	SELL	$145.58 - $192.14 $1.25 Million - $1.65 Million	-8,584 Reduced 16.02%	45,015 $6.55 Million
Q2 2021 Aug 03, 2021	SELL	$134.22 - $202.37 $16.7 Million - $25.2 Million	-124,652 Reduced 69.93%	53,599 $10.5 Million
Q1 2021 May 04, 2021	SELL	$140.25 - $196.86 $333,935 - $468,723	-2,381 Reduced 1.32%	178,251 $32.3 Million
Q4 2020 Feb 01, 2021	SELL	$126.47 - $163.7 $2.98 Million - $3.86 Million	-23,584 Reduced 11.55%	180,632 $25.6 Million
Q3 2020 Nov 09, 2020	SELL	$87.44 - $125.0 $2.37 Million - $3.38 Million	-27,053 Reduced 11.7%	204,216 $25.5 Million
Q2 2020 Aug 07, 2020	SELL	$58.39 - $89.31 $7.41 Million - $11.3 Million	-126,970 Reduced 35.44%	231,269 $20.7 Million
Q1 2020 May 04, 2020	SELL	$51.57 - $106.62 $4.98 Million - $10.3 Million	-96,655 Reduced 21.25%	358,239 $22.3 Million
Q4 2019 Feb 06, 2020	BUY	$46.07 - $79.54 $236,707 - $408,676	5,138 Added 1.14%	454,894 $34.7 Million
Q4 2019 Feb 04, 2020	SELL	$46.07 - $79.54 $5.16 Million - $8.9 Million	-111,918 Reduced 19.93%	449,756 $41.1 Million
Q3 2019 Nov 12, 2019	BUY	$49.99 - $62.0 $28.1 Million - $34.8 Million	561,674 New	561,674 $28.3 Million

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc 10x Genomics, Inc. Transaction History